Back to Journals » The Application of Clinical Genetics » Volume 6

Association of PPARγ2 gene variant Pro12Ala polymorphism with hypertension and obesity in the aboriginal Qatari population known for being consanguineous

Authors Bener A, Darwish S, Al-Hamaq A, Mohammad RM, Yousafzai MT

Received 13 June 2013

Accepted for publication 31 July 2013

Published 24 October 2013 Volume 2013:6 Pages 103—111

DOI https://doi.org/10.2147/TACG.S49875

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4


Abdulbari Bener,1,2 Sarah Darwish,3 Abdulla OAA Al-Hamaq,4 Ramzi M Mohammad,5,6 Mohammad T Yousafzai1

1Department of Medical Statistics and Epidemiology, Hamad Medical Corporation, Department of Public Health, Weill Cornell Medical College, Doha, Qatar; 2Department of Evidence for Population Health Unit, School of Epidemiology and Health Sciences, University of Manchester, Manchester, UK; 3Department of Endocrinology, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar; 4Qatar Diabetic Associations and Qatar Foundation, Doha, Qatar; 5Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University, School of Medicine, MI, USA; 6Department of Medicine, Hamad Medical Corporation, Doha, Qatar

Aim: The aim of this study was to investigate the association of the Pro12Ala polymorphism of the human peroxisome proliferator-activated receptor gamma 2 (PPARγ2) gene with hypertension and obesity in a highly consanguineous aboriginal Qatari population.
Design: A cross-sectional survey conducted from January 2011–December 2012.
Setting: Primary health care clinics.
Subjects: A random sample of 1,528 Qatari male and female population older than 20 years of age.
Materials and methods: Data on age, sex, income, level of education, occupation status, body mass index, and blood pressure and lipid profile were obtained. The Pro12Ala in the PPARγ2 gene was detected on the LightCycler® using two specific probes: (Sensor [G] 5'-CTC CTA TTG ACG CAG AAA GCG-FL and PPAR Anchor 5' LC Red 640- TCC TTC ACT GAT ACA CTG TCT GCA AAC ATA TC-PH). Univariate and multivariate logistic regression were performed.
Result: Out of a total 1,528 participants, 220 were diagnosed with essential hypertension, and 420 were obese. Participants with consanguinity were significantly higher among hypertensive than normotensive (41.9% versus 30.8%; P=0.001). Altogether, more than three-fourths (89%) of the participants had a wild genotype (Pro12Pro), 9.8% were heterozygous with Pro12Ala, and only 1.2% was homozygous with the Ala12Ala genotype. The frequency of the Pro allele was 94.5% in normotensive versus 90.5% in hypertensive, while the distribution of the Ala allele was 5.5% in normotensive versus 9.5% in the hypertensive group (P=0.001). The odds of hypertension were 1.7 times higher among the participants with the Ala allele as compared to those with the Pro, while adjusting for other potential confounders (adjusted odds ratio 1.69; 95% confidence interval 1.12–2.55; P=0.012). There was no association between the PPARγ2Ala allele and obesity (P=0.740).
Conclusion: The current study revealed an association between the PPARγ2Ala allele and hypertension in Qatar's population. On the other hand, this study found no association between the Ala allele and obesity.

Keywords: hypertension, PPARγ2 gene, consanguinity, obesity, Pro12Ala polymorphism

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]